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Abstract
Motivation: Estimating differentiation potency of single cells is a task of great biological and clinical significance, as it may
allow identification of normal and cancer stem cell phenotypes. However, very few single-cell potency models have been
proposed, and their robustness and reliability across independent studies have not yet been fully assessed.
Results: Using nine independent single-cell RNA-Seq experiments, we here compare four different single-cell potency
models to each other, in their ability to discriminate cells that ought to differ in terms of differentiation potency. Two of the
potency models approximate potency via network entropy measures that integrate the single-cell RNA-Seq profile of a cell
with a protein interaction network. The comparison between the four models reveals that integration of RNA-Seq data with
a protein interaction network dramatically improves the robustness and reliability of single-cell potency estimates. We
demonstrate that underlying this robustness is a correlation relationship, according to which high differentiation potency is
positively associated with overexpression of network hubs. We further show that overexpressed network hubs are strongly
enriched for ribosomal mitochondrial proteins, suggesting that their mRNA levels may provide a universal marker of a cell’s
potency. Thus, this study provides novel systems-biological insight into cellular potency and may provide a foundation for
improved models of differentiation potency with far-reaching implications for the discovery of novel stem cell or progenitor
cell phenotypes.
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Introduction
Over 60 years agoWaddington proposed an epigenetic landscape
model of cellular differentiation, whereby cell fate transitions
are modeled as canalization events, with stable cell states defin-
ing the attractors or basins in this landscape [1, 2]. Focusing on
a given cell lineage, a key ingredient of this landscape is the
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with differentiation potency, i.e. the relative number of down-
stream cell fate choices a given cell may have. Quantifying the
differentiation potency of single cells is a task of critical impor-
tance, as it may help estimate potency heterogeneity within
otherwise seemingly homogenous cell populations [4], it may
facilitate explicit construction of Waddington landscapes [2, 5]
and provide an unbiased means of identifying novel stem or
progenitor cell phenotypes [6].
Given that mRNA expression levels of genes in a cell may
inform on the activity of transcription factors and associated
signaling pathways that control pluri-and-multi potency [7], it
is reasonable to assume that differentiation potency is encoded
by the genome-wide transcriptomic profile of the cell [6, 8–10].
Following this rationale, a number of explicit potency models
based on biological principles have been proposed [6, 9–13].
For instance, StemID [6] estimates potency of a cell in terms
of its genome-wide transcriptomic entropy, which measures
how uniformly expressed the genes are. Because stemness is
characterized by large numbers of differentiation expression
programs being kept at a low and comparable level of basal
activity, this transcriptomic entropy may therefore approximate
potency. Another proposed model, called SLICE [9], groups genes
into Gene-Ontology (GO) clusters and approximates potency of a
cell in terms of a Shannon entropy, defined over gene expression
derived activity estimates for each GO cluster: in effect, this
measures the degree of uniformity of the GO-cluster activation
levels and thus the degree of uniformity in the activation levels
of different biological processes in a cell. A third model, called
SCENT [10], integrates the single-cell RNA-Seq (scRNA-Seq) pro-
file of a cell with a protein–protein interaction (PPI) network,
modeling potency in terms of how efficient signaling can diffuse
over the whole network. The efficiency of the diffusion process
is estimated by the signaling entropy rate, which is expected to
be lower for differentiated cells, since differentiation is accom-
panied by activation of a specific subnetwork, which in effect
draws signaling flux away from other parts of the network [10].
Importantly, SCENT has been shown to estimate potency not
only of normal cells, but also of cancer cells allowing putative
cancer stem cell phenotypes to be identified [10].
Given the importance of estimating single-cell potency, a
comparison of these different potencymodels is of great interest,
and here we do so by performing a comprehensive comparison
across a large number of independent scRNA-Seq datasets all
profiling normal cells, in order to objectively determine which
single-cell potency models are most accurate and robust. We do
this in both single-cell aswell as bulk-sample settings,while also
adjusting for cell-cycle phase, which is a major confounder in
scRNA-Seq studies. In performing these comparisons, we also
introduce a novel single-cell potency measure, called Markov
Chain Entropy (MCE), which like SCENT integrates the scRNA-
Seq profile of a cell with a PPI network. Our results highlight
that SLICE and StemID are less robust than SCENT/MCE in both
single-cell and bulk tissue settings.We provide a detailed expla-
nation and understanding as to the factors driving the increased
robustness of MCE and SCENT, revealing that potency can be




We here describe the construction of MCE to represent the
potency of a sample with a scRNA-Seq or bulk RNA-Seq profile.
The construction requires two inputs, i.e. the normalized RNA-
Seq profile and a fully connected signaling interaction network
between the genes defined in the profile. For the network,we use
the PPI network of 8434 proteins from [10].We note that although
in principle we could infer a gene regulatory network from the
scRNA-Seq data itself using one of the many available methods
[43–47], this does not work as well as using a PPI network, for
reasons given later. Given a network/graph G = {V,E} with nV
nodes in V and nE edges in E, we model signaling as a particle on
thenetwork and let it do discrete-timeMarkov transition.Denote
the transition probability matrix as P = {pij}, where i, j = 1, . . . ,nE.
We set pij = 0 if there is no edge between two different nodes
i and j. pii can be nonzero and is the probability of the particle
staying at node i. We assume the network has a steady state
with invariant distribution π = (π1, . . . ,πnV ) after the particle
walks for long enough time. As we shall see below, the invariant
measure or steady-state probabilities will be determined from
the sample’s gene expression profile.
TheMarkov Chain Entropy of theMarkov transition on network





where the summation is only for the terms pij > 0, and E¯ is the












where N (i) contains all the neighbors of node i including i itself.
The first term in Equation (2) is named as the edge entropy
(similar to but not the same as the average local entropy/
signaling entropy in [10, 42]), and the second term is called the
node entropy. Since πipij means the probability (or information
flow or actual interaction) transmitted from i to j along the
directed edge (i, j) in E, MCE is indeed the whole entropy of the
information flow induced by the Markov chain on the graph or
network G, rather than the entropy rate [10, 42]). Thus, it can be
thought as a measurement of the heterogeneity of a network in
terms of actual interactions. The more homogeneous of interac-
tions the graph is, the bigger its MCE grows. We think that this
intuition can be utilized to characterize the stemness of cells.
Computing MCE from single-cell RNA-seq dataset
Denote the dataset as X = {x(1),x(2), . . . ,x(n)}, where n is the
sample size, and x(i) is a length-nV column vector for gene
expressions. nV is not only the number of genes in consideration
but also the counts of nodes in the gene network.
Computing MCE for each sample
Denote the 0–1 adjacency matrix of the PPI network as A, whose
diagonal elements are also set to be 1s. For convenience, we still
use X as the data matrix, and the size of A is nV × nV. We have
two assumptions before calculating the MCE for a single-cell
sample x:
i. The normalized gene expression π = x/||x||L1 is the invari-
ant distribution of a discrete-time Markov transition matrix
P on the gene network A;
ii. Among all the possible transition matrix P with invariant
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(i,j)∈ E¯ πipij log(πipij) (3)
subject to
∑
j∈N (i) pij = 1, i = 1, . . . ,nV,
∑
i∈N ( j) πipij = πj, j = 1, . . . ,nV,
where the summation is only for the elements (i, j) ∈ E¯ satisfying
Aij = 1, and N (i) includes node i and all its neighbors.
Because π is known (so is the node entropy), the above can





(i,j)∈ E¯ πipij log(pij) (4)
s.t. P1 = 1,
πP = π ,
where P = (pij)nV×nV has the same topology as A, and variables
only are located at the position of 1s in A. Though the prob-
lem Equation (4) is convex with linear constraints, there are
about O(n2V) variables, which means to find an almost million-
dimension optimizer for one cell! It sounds like infeasible for
the first look, but luckily we can change the variables into its


























Calculate the 1st derivations of (5) we get
πi log pij + πi − λi − πiμj = 0, (i, j) ∈ E¯, i, j = 1, . . . ,nV,
∑
j∈N (i)
pij = 1, i = 1, . . . ,nV,
∑
i∈N ( j)
πipij = πj, j = 1, . . . ,nV,
where only the terms pij ≥ 0 corresponding to Aij = 1 are used
in the equations. Denote αi = exp(λi/πi), βj = exp(μj − 1) and
pij = αiβjaij, then we have transformed the optimization problem











πiαi = πj, j = 1, . . . ,nV. (6)
There are fortunately 2nV nonlinear equations corresponding to
2nV variables.
We propose an iterationmethod to solve the equations (6) as
1. α(n) = 1./(Aβ(n−1));
2. β(n) = π ./(B′α(n)),
where A is the adjacency matrix, B is got by multiplying each
element in row i of A by πi (i.e. bij = πiaij), and ‘./’ means division
by elements. With a proper initial point β(0), we can do the
iteration until (α(n),β(n)) converging into a fixed point (α∗,β∗).















πi log α∗i −
∑
j











To normalize the MCE into [0, 1], we should compute the maxi-
mum possible MCE of all the networks with topology A. Accord-
ing to the formation of MCE in Equation (1), the maximum is
reached when πi ∼ di and pij = 1/di, where di is the degree of
node i (including i itself). Denote d = ∑i di which is equal to the
count of nonzero terms in A. Thus, we have
maxMCE = log(d), (7)






Signaling entropy (SR) was proposed in [8, 10, 42]. It requires the
specification of a gene functional network, e.g. a PPI network.
The weights on the edges of this network are assumed to be
proportional to the normalized expression levels of the genes,






where N (i) means the neighbors of node i and A is the PPI
adjacencymatrix.With detailed balance condition and invariant
measure π computed from P as πi = xi(Ax)i/(x′Ax), signaling







pij log pij. (10)
To normalize the signaling entropy, maximum entropy is com-
puted by
maxSr = log λ, (11)
where λ is the largest eigenvalue of adjacencymatrix A. Normal-




The main difference between SR and MCE are
i. The adjacent matrix A has zero diagonal elements in SR,
while it has ones in MCE. The basis of SR is interaction
between proteins through the law of mass action, while the
basis of MCE is a Markov transition on the gene network.
The signaling particle in MCE has a probability to stay at
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ii. For MCE, we maximize the entropy to get the most likely
transition matrix given a fixed invariant measure. In con-
trast, when computing SR, the weights of the stochastic
matrix P are precomputed using the law of mass action,
which is therefore fixed.
StemID
Grün et al.proposed the StemID algorithm to estimate differenti-
ation potency of single cells in [6]. This algorithm does not use a
PPI network. Strictly speaking it is also not a single-cell potency
model, because it combines the computation of potency with
a prior clustering step, which therefore uses information from
all cells in the study. Specifically, StemID computes a stemness
score s for each inferred cluster of cells as
Ek = medianj∈k(Ej) − minl(medianj∈l(Ej)), (13)
sk ∝ Ek, (14)
where k and l label clusters, and where Ej is the entropy of cell
j defined as Ej = −∑Ni=1 pi,j logN pi,j, with N the total number of
genes and pi,j the normalized number of reads mapping to gene i
in cell j. Thus, to compare fairly and objectively to other entropy
indices like SR and MCE, we take Ej as the potency estimate
from StemID for each cell. Importantly, we note that the StemID
entropy is computed on the normalized (unlogged) counts, as
recommended in the original paper [6].
SLICE
SLICE is another entropy-based index proposed in [9]. Like
StemID it does not use a PPI network. Instead, it first clusters
genes intom functional GO clusters, according to their similarity
of GO annotation. For each cell j, SLICE then computes a
probability activity score pj,k for GO-cluster k in cell j, by taking
the average expression of genesmapping to a given GO-cluster k.
Subsequently, it approximates potency as the Shannon entropy
of the activity distribution, i.e. as Hj = E[−∑mk=1 pj,k log pj,k],
where the expectation is taken over a number of bootstraps.
We computed SLICE as described in [10] using the R-functions
provided by Guo et al. [9]. We note that, as with StemID, the
computation of SLICE entropy is supposed to be done on the
unlogged normalized counts. Thus, we used the downloaded
normalized count data matrices when estimating SLICE entropy.
The expression threshold parameter in SLICE was set to 1
(default value) for all studies, except for Yao1 where the
data were already regularized (logged) and where we used a
threshold of 0.1. We note that in the Yao1 study data have
been renormalized by subsampling single cells to 20 000 unique
molecular identifiers (UMIs) [14].
Single-cell and bulk RNA-Seq datasets
In total, we used scRNA-Seq datasets derived from nine inde-
pendent studies. Two of these studies contained matched bulk
RNA-Seq data. From all of these scRNA-Seq studies, we devised
11 independent analyses, comparing in each one cells of high
potency to cells of low potency, assessing the different potency
measures in their ability to discriminate these cell types. In the
case of bulk RNA-Seq data, we devised five independent com-
parisons from the two studies with bulk RNA-Seq data. Table 1
gives a brief summary of the 11 independent comparisons per-
formed on scRNA-Seq data and the five performed using bulk
RNA-Seq data. A more detailed description of the datasets is
listed below:
• Chu et al. datasets 1–4: These datasets were derived from
[38]. There are four experiments named Chu1, Chu2, Chu3
and Chu4. Chu1 dataset contains scRNA-Seq data for 1018
single cells, which is composed of 374 hESCs (human
embryonic stem cells, 212 from H1 cell line and 162 from
H9 cell line), 173 NPCs (neuronal progenitor cells, ectoderm
derivatives), 138 DECs (definitive endoderm cells, endo-
derm derivatives), 105 ECs [endothelial cells, mesoderm
progenitors (MPs)/derivatives], 69 TBs (trophoblast-like cells,
extraembryonic derivatives) and 159 HFFs (human foreskin
fibroblasts). The hESCs are pluripotent (n = 374) and the
others are non-pluripotent (n = 644). Chu2 dataset is a time-
course differentiation of single cells, in which hESCs were
induced to differentiate into DECs, via a mesoendoderm
intermediate. The time points cover before induction at
t = 0 h (n = 92) and after induction at t = 12 h (n = 102),
t = 24 h (n = 66), t = 36 h (n = 172), t = 72 h (n = 138) and
t = 96 h (n = 188). There are 758 single cells in total. Chu3
dataset is from bulk samples. There are 19 bulk samples,
which have seven samples for hESCs, two for NPCs, two for
TBs, three for HFFs, three for ECs (MPs) and two for DECs.
Chu4 is the time-course experiment of 15 bulk samples,
consisting of three samples for each of five time points
(12 h, 24 h, 36 h, 72 h and 96 h). Normalized data were
downloaded from Gene Expression Omnibus (GEO) under
accession number GSE75748 (files: GSE75748-bulk-cell-type-
ec.csv, GSE75748-sc-cell-type-ec.csv, GSE75748-bulk-time-
course-ec.csv, GSE75748-sc-time-course-ec.csv).
• Trapnell et al. dataset: This scRNA-Seq dataset was derived
from [29]. It represents a time-course differentiation experi-
ment of humanmyoblasts into human skeletalmuscle cells.
Human myoblasts were induced at t = 0 h (n = 96). Samples
were also taken at t = 24 h (n = 96), t = 48 h (n = 96)
and t = 96 h (n = 84) after induction. There are 372 single
cells in total. Normalized data were downloaded from GEO
under accession number GSE52529 (file: GSE52529-fpkm-
matrix.txt).
• Treutlein et al. dataset: This dataset was derived from [39]. The
experiment took samples from the developing mouse lung
epithelium at embryonic days E14.5 (n = 45), E16.5 (n = 27),
E18.5 (n = 83) and adulthood (n = 46), totalling 201 single
cells. Normalized data were downloaded from GEO under
accession number GSE52583 (file: GSE52583.Rda).
• SemrauRB and SemrauSS datasets: The two datasets named
SemrauRB and SemrauSS were derived from [40], a study
of retinoic acid (RA)-driven differentiation of pluripotent
mouse embryonic stem cells (mESCs) to lineage commit-
ment. SemrauRB used a recently developed Single Cell RNA
Barcoding and Sequencing method (SCRB-seq) and consists
of 425 single-cell samples taken at nine time points during
mouse embryonic differentiation. There were 53 single cells
taken at 0 h. After all-trans RA exposure, 73 samples were
taken at 6 h, 49 samples at 12 h, 27 samples at 24 h, 72
samples at 36 h, 43 samples at 48 h, 54 samples at 60 h,
29 samples at 72 h and 25 samples at 96 h. To increase
power and because exit from pluripotency occurs after 12 h
[40], all cells from 0–12 h were considered to be pluripotent.
SemrauSS uses a different scRNA-Seq technology (SMART-
seq). A total of 292 single cells were taken at four time points
(75 samples at 0 h, 75 samples at 12 h, 81 samples at 24 h
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Table 1. Summary of RNA-Seq experiments used. Table lists the name of the experiment, the type of RNA-Seq data (if single cell or bulk), the
species, the total number of profiles (after quality control), the time points or potency states being compared, the cell types being compared, the
number of single cells in each comparison group and the reference. Chu1–4 derive from Chu et al., Trapnell derives from Trapnell et al., Treutlein
from Treutlein et al., SemrauRB & SemrauSS derive from the RNA Barcoding (RB) and Smart-Seq (SS) scRNA-Seq experiments in Semrau et al.,
WangNPC derives fromWang et al., YangML derives from Yang et al. and Yao1 derives from a scRNA-Seq experiment that used UMIs, while Yao2
is a corresponding matched bulk RNA-Seq dataset. Abbreviations: Pl, pluripotent; NonPl, non-pluripotent; E,embryonic day; h, hours; d, day,MP,
multipotent progenitor; NPC, neural progenitor cell. For instance, for Chu1 set, we tested the alternative hypothesis that the potency measure
is higher in the pluripotent cells compared to non-pluripotent cells, and of the 1018 high-quality scRNA-Seq profiles, 374 were pluripotent and
644 were non-pluripotent
Name Type Species Total number Comparison Cell types in comparison Numbers in comparison Ref
(after QC)
Chu1 scRNA Human 1018 Pl >NonPl hESCs to MPs 374 versus 644 [38]
Chu2 scRNA Human 758 0 h >96 h hESCs to MPs 92 versus 188 [38]
Trapnell scRNA Human 372 0 h >72 h Myoblasts to skeletal muscle 96 versus 84 [29]
Treutlein scRNA Mouse 201 E14 >Adult Lung Differentiation 45 versus 46 [39]
SemrauRB scRNA Mouse 425 0–12 h >96 h hESCs to MPs 175 versus 25 [40]
SemrauSS scRNA Mouse 292 0 h >48 h hESCs to MPs 75 versus 61 [40]
WangNPC scRNA Human 483 0–1 d >30 d NPCs to Neurons 158 versus 81 [17]
YangML scRNA Mouse 447 E10 >E17 Liver Differentiation 54 versus 70 [16]
Yao1a scRNA Human 2684 0 d >26 d hESCs to NPCs 40 versus 595 [14]
Yao1b scRNA Human 2684 0 d >54 d hESCs to Neurons 40 versus 765 [14]
Yao1c scRNA Human 2684 26 d >54 d NPCs to Neurons 595 versus 765 [14]
Chu3 bulkRNA Human 19 Pl >NonPl hESCs to MPs 7 versus 12 [38]
Chu4 bulkRNA Human 15 12/24 h >72/96 h hESCs to definite endoderm 6 versus 6 [38]
Yao2a bulkRNA Human 33 0–9 d >26 d hESCs to NPCs 12 versus 6 [14]
Yao2b bulkRNA Human 33 0–9 d >54 d hESCs to Neurons 12 versus 4 [14]
Yao2c bulkRNA Human 33 26 d >54 d NPCs to Neurons 6 versus 4 [14]








• Wang et al. dataset: This dataset was derived from [17],
a study of non-directed differentiation over a 30-day period
of neural progenitor cells (NPCs) into developing neurons,
with the NPCs derived from hESCs. After quality control,
there were 483 usable single cell samples describing the
differentiation from NPCs (at day 0) to neurons and other
differentiated cell-types. Cell numbers were 80 at day 0, 78
at day 1, 85 at day 5, 80 at day 7, 79 at day 10 and 81 at
day 30. Normalized data were downloaded from GEO under
accession number GSE102066 (file: GSE102066-normalized-
counts.experiment1.DataMatrix.txt).
• Yang et al. dataset: This scRNA-Seq dataset was derived from
[16], a study of differentiation of mouse hepatoblasts into
hepatocytes and cholangiocytes. After quality control, 447
single-cell samples were taken during embryonic develop-
ment. There are 54 single cells at embryonic day 10.5 (E10.5),
70 at E11.5, 41 at E12.5, 65 at E13.5, 70 at 14.5, 77 at 15.5 and
70 at E17.5. Normalized data were downloaded from GEO
under accession number GSE90047 (file: GSE90047-Single-
cell-RNA-seq-TPM.txt).
• Yao et al. datasets 1–2: This scRNA-Seq dataset (Yao1) was
obtained by using a method based on multiplexed single-
cell RNA-seq (CelSeq) and UMIs [14]. Cel-Seq was used to
profile cells at multiple time points (days 0, 12, 19, 26, 40
and 54) in a study of differentiation of hESCs into corti-
cal and non-cortical progenitor and finally into neurons.
After quality control, there were 2684 single cells: 40 hESCs,
504 collected at day 12, 278 at day 19, 595 at day 26, 502
at day 40 and 765 at day 54. Progenitor expansion into
neurons occurred at day 26. Normalized data were down-
loaded from GEO under accession number GSE86977 (file:
GSE86977-UMI-20K.2684.csv). In addition,we also analyzed a
matched bulk RNA-Seq dataset (Yao2) from the same study,
encompassing a total of 33 samples: five hESC samples
(day 0), three samples at day 6, four samples at day 9, six
samples at day 12, five samples at day 19, six samples at
day 26 and four samples at day54. Normalized data were
downloaded from GEO under accession number GSE86985
(file: GSE86985-trueseq.tpm.csv).
Further processing and quality control analysis
We used the following general procedure to further assess qual-
ity and further normalize the provided scRNA-Seq data. First, in
all cases, we computed the coverage per single cell, i.e. the num-
ber of genes with normalized counts (e.g. transcripts per million
(TPM) fragment reads per kilobase exon per million (FPKM))
above zero. Any single cell with less than 10% coverage was
removed. Next, we quantile normalized (QN) the resulting
dataset to remove potential batch effects. For most datasets,
we then renormalized the minimum read count to 1, i.e. any
normalized count less than 1 was renormalized to 1. We justify
this on the basis that the normalized counts of 1 and 0 are
effectively indistinguishable. The threshold of 1 was derived by
inspection of the distribution of normalized counts. After QN,
we log2-transformed the data with an offset value of 0.1 added
before log-transformation. The offset was added in order to
ensure that the minimum value after log-transformation would
not be 0, but a nonzero value (typically log2 1.1 ≈ 0.13). We did
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the computation of the signaling entropy rate used in SCENT.
The log-transformation was done to stabilize the variance and
regularize the effects of outliers.Next, in the case of human data,
we mapped gene symbols to Entrez gene IDs (if not annotated
to Entrez gene IDs already) and finally averaged any entry
mapping to the same Entrez gene ID. In the case of mouse,
we first obtained the human homologs using the annotationTools
Bioconductor package (http://www.bioconductor.org) and finally
mapped to human Entrez gene IDs. The typical range of a re-
sulting data matrix was then typically 0.13 to approximately 16.
We note that the Yao1 scRNA-Seq dataset used CelSeq-
technology and UMIs and was normalized using a different
procedure as described in [14]. For this dataset, we therefore
used a slightly different choice of thresholds. First, the data
downloaded was already on a log-scale, but still with a few
significant outliers: thus, we regularized the data further by
setting any values larger than 16 to 16. We then performed QN
and finally any value less than 1was set to a value of 0.1 (in order
to remove zeroes from the data matrix).
The above procedure resulted in data matrices defined over
human Entrez gene IDs and single cells of following dimen-
sions: Chu1 (18 935 genes, 1018 single cells), Chu2 (18 935 genes,
758 single cells), Chu3 (18 935 genes, 19 bulk samples), Chu4
(18 935 genes, 15 bulk samples), Trapnell (22 351 genes, 372 single
cells), Treutlein (12 413 genes, 201 single cells), SemrauRB (13 755
genes, 425 single cells), SemrauSS (13 663 genes, 292 single cells),
WangNPC (8242 genes, 483 single cells), YangML (16 119 genes,
447 single cells), Yao1 (22 113 genes, 2684 single cells) and Yao2
(19 659 genes, 33 bulk samples).
Evaluation framework
In order to compare the different potencymeasures (described in
the next subsections), we assessed their ability to discriminate
single cells (and bulk samples) that ought to differ substantially
in terms of their potencies. We reasoned that potency measures
which would fail to discriminate such cell types would be less
preferable than those that are more robust. For each of the
studies, we therefore devised comparisons between cell types
(or bulk samples) where typically we would expect to see a big
difference in potency, so that it is reasonable to assume that
higher Area Under the Curves (AUCs) (discriminatory ability) and
more significant P-values (as derived using one-tailed Wilcoxon
rank sum tests) would indicate better potency measures. For
the scRNA-Seq datasets, we devised a total of 11 independent
comparisons, where the specific cell types being compared and
the corresponding cell numbers are given in Table 1. Below, we
briefly summarize the comparisons.
In Chu1, we chose to compare the pluripotent hESCs to all
progenitor and non-pluripotent cell types. In Chu2,we compared
the hESCs at time 0 to the final time point (96 h) corresponding
to definite mesoderm/endoderm (i.e. non-pluripotent). For the
corresponding bulk sets Chu3 and Chu4, we chose the same
groups, although for Chu4 only 12 h and 24 h were available to
represent the pluripotent state, so for Chu4we compared 12 h/24
h to 72 h/96 h, which yielded six samples in each group. Only
using 12 h and 96 h would result in too few samples. We also
note that the transition to the definite mesoendoderm occurs at
72 h and beyond. In Trapnell, we compared the myoblasts at 0
h to the differentiated skeletal muscle cells at 72 h. In Treutlein,
we compared embryonic day E14 to the adult differentiated cells.
In SemrauRB, because exit from pluripotency occurs after 12 h
and because cell numbers at each time point were fairly low, we
compared all cells harvested at 0, 6 and 12 h to those harvested
at 96 h. In SemrauSS, we compared cells at 0–48 h. In WangNPC,
we compared neural progenitors at 0 and 1 day to differentiated
neural cells at 30 days.We deemed safe to bunch together 0 and 1
day cells as differentiation occurred much later in the assay and
to increase cell numbers for the more potent NPC phenotype. In
YangML,we compared embryonic day 10 (E10) to E17 single cells.
In Yao1, we devised three separate comparisons, because in this
study there weremany single cells and because the nature of the
experiment allowed precise definition of three potency states:
hESCs at day 0, cortical and non-cortical progenitors at day 26
and differentiated neurons at 54 days. Thus, in Yao1a we com-
pared day 0 to day 26, in Yao1b,we compared day 0 to day 54, and
in Yao1c we compared day 26 to day 54. For the corresponding
bulk sample study, Yao2, we also performed three comparisons,
but in order to increase sample numbers we considered the
pluripotent state to also include day 9 samples,which is justified
based on the findings of the original publication [14].
Adjusting for cell-cycle phase
Differences in cell potency between groups could be confounded
by differences in the proportion of cycling versus non-cycling
cells. For each single cell we thus computed two cell-cycle
scores (one for the G1-S and the other for the G2-M phase),
using the procedure described in [10, 41]. Because the relation
between potency and cell-cycle scores could be highly nonlinear
(as described in [10]), linear adjustment procedures are inap-
propriate. Another approach to compare potency of cell types,
adjusted for cell cycle, would be to set a threshold on the scores
and only use cells with cell-cycle scores below a given threshold.
However, these thresholds may be study-specific, and we found
that if we were to use the same threshold for all studies, that
this may lead for specific studies to highly unequal numbers
of low-cycling cells in each comparison group or to effectively
no cells in a given group. For instance, in some studies we find
that all single hESCs exhibit relatively high-cycling scores. This
indicates that disentangling cell-cycle effects and potency is
extremely difficult, if not impossible, and may also be strongly
dependent on the experimental details (e.g. culture conditions
of cells, etc.). Thus, we decided on a different approach which
would allow us to compare cell types, while adjusting for cell-
cycle phase as much as possible. Specifically, for each study and
cell type of interest,we chose a lower quantile of cell-cycle scores
based on the scores of all cells within that cell type. Doing so,
ensure that we are comparing sufficient numbers of single cells
within each group, but also that we are using the lowest-cycling
cells within each group. The quantiles were chosen to ensure
sufficient numbers of cells in each comparison group. We note
that since there are two cell-cycle scores, which we performed
this operation on G1-S and G2-M separately, subsequently only
using the single cells that were in the lower-defined quantile
for both phases. Thus, absolute cell numbers could be low for
some studies, but with the chosen quantiles enough cells were
being compared to achieve potential statistical significance. The
quantiles chosen, the number of low-cycling single cells in each
comparison group and the results obtained are listed in Table S2.
Construction of a model landscape
We first use t-stochastic neighborhood embedding (t-SNE) [48]
to dimensionally reduce and visualize the single-cell data,
projecting the data onto a lower two-dimensional space. The
t-SNE coordinate values are used to model the x and y axes. MCE
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figure, cells located higher up along the z-axis are more potent
as they have higher entropy. To plot an illustrative potential
landscape, we use a function like















h(x, y) =8f(x, y) + y,
and plot the height values of h(x, y) for (x, y) ∈ [0, 1] × [−1, 4].
The idea of constructing such landscape function is to make it a
Gaussian mixture in x-direction but linear in y-direction. Finally,
we place the surface at the right height in the tSNE-MCE figure.
We point out that the resulting surface map is only intended as
an illustration of Waddington’s landscape to merely show how
stem cells differentiate into multipotent cells from the three
main germ layers.
Results
Modeling single-cell potency as the graph entropy
of a Markov chain process
The measured mRNA expression profile of a cell can be inter-
preted as the net result of a complex signaling process that
takes place in the cell. Assuming an interaction network (e.g. a
PPI network), one may thus attempt to model a given signaling
process in terms of a Markov chain that is consistent with the
observed expression profile of the cell (Methods, Figure 1A).
For each Markov-chain process one can further define an
associated graph entropy, here termed MCE, that measures the
overall uniformity of the signaling fluxes in the network (Meth-
ods, Figure 1A).We posited that among all Markov chains consis-
tent with the observed expression profile, the one maximizing
the graph entropy could provide us with an estimate of single-
cell potency (Methods, Figure 1A). To understand this, we note
that higher entropy means a more uniform Markov chain sig-
naling process on the network, allowing signaling information
to diffusemore efficiently.Thus, since a terminally differentiated
cell (a cell of lowest potency) is characterized by the activation
of specific signaling subnetworks (i.e. signaling pathways), it is
plausible that this nonuniformity can be detected in terms of a
lower MCE.
Comparison of single-cell potency measure reveals
robustness of MCE and SCENT
To compare the different single-cell potency models we devised
an evaluation framework, designed to be as objective as pos-
sible: we reasoned that although a population of seemingly
equally potent single cells may not be entirely so due to inter-
cellular heterogeneity a reliable potency measure should be able
to nevertheless discriminate single-cell populations that differ
significantly in terms of differentiation potency. For instance,
a robust single-cell potency measure should be able to dis-
criminate pluripotent from non-pluripotent cell populations or
cells at the start and endpoints in time-course differentiation
experiments. Thus, we assembled a collection of nine scRNA-
Seq experiments, encompassing a total of approximately 6700
high-quality scRNA-Seq profiles, fromwhichwe devised 11 inde-
pendent comparisons between cell types that ought to differ sig-
nificantly in terms of differentiation potency (Methods, Table 1).
To each of these datasets, we applied the three previously
proposed single-cell potency models (StemID [6], SLICE [9] and
SCENT [10]), as well as MCE.
We first considered a time-course differentiation experiment
in which hESCs were induced to differentiate into cortical NPCs
and finally into neurons over a 54 day period, with scRNA-Seq
measurements taken at six time points, encompassing a total
of 2684 single cells [14]. While MCE and SCENT showed the
expected gradual decrease of potency with differentiation time
point, StemID exhibited a less significant pattern, while SLICE
did not exhibit a decrease (Figure 2A).
Comparing hESCs to NPCs at day 26 (Figure 2A, Yao1a in
Table 1) and separately hESCs to differentiated neurons at day 54
(Figure 2A, Yao1b in Table 1) revealed that SCENT and MCE could
discriminate cells with almost perfect accuracy (see Yao1a and
Yao1b in Figure 2B, Supplementary Table S1). As expected the
difference in potency between NPCs and neurons (Yao1c in
Table 1) was less strong but still significantly stronger than the
differences predicted by StemID or SLICE (see Yao1c in Figure 2B,
Supplementary Table S1). As assessed over the 11 independent
comparisons (Table 1, Supplementary Figure S1), we observed
that MCE and SCENT outperformed the other two (SLICE and
StemID), also when adjusted for cell-cycle phase (Figure 2B and
C, Supplementary Tables S1 and S2, Methods). In 9/11 compar-
isons, MCE and SCENT were better than StemID, and in all 11
better than SLICE. The better performance of MCE and SCENT
was statistically significant under a paired Wilcoxon test over
the 11 comparisons (Figure 2B and C).
MCE and SCENT outperform other potency models
on bulk RNA-Seq data
Since potency is also a property of a cell population [10, 15],
any robust measure of single-cell potency should, in principle,
also work for bulk samples since a bulk RNA-Seq profile is
effectively an average over single cells [8].We observed that only
SCENT and MCE exhibited a robust performance on bulk sam-
ples (Supplementary Table S3), in line with the results obtained
on scRNA-Seq data. Thus, based on the comparative analysis
performed here, we conclude that SCENT and MCE currently
provide the more robust measures of cell potency, and there-
fore advocate their use for explicit, unbiased construction of
Waddington landscapes. For instance, we applied MCE to the
Chu1 dataset (Table 1, Methods), in combination with t-SNE [48],
to construct a Waddington epigenetic landscape encompassing
four attractor states, representing pluripotent hESCs and mul-
tipotent (i.e. non-pluripotent) progenitors from the three main
germ layers: ectoderm, mesoderm and endoderm (Figure 1B).
MCE correctly predicts differentiation time points
To further validate MCE we applied it to two different time-
course differentiation experiments, generating three-dimen-
sional representations of cell-lineage trajectories. For an
embryonic time-course differentiation experiment of mouse
hepatoblasts into hepatocytes and cholangiocytes (Yang et al.,
Table 1), MCE predicted separation after embryonic day 13
(Figure 3A), consistent with the findings of [16]. When applied
to a 30 day time-course differentiation experiment of neural
progenitor cells into neurons (Wang et al., Table 1), MCE
correctly predicted a gradual decrease in potency (Figure 3B,
Supplementary Figure S1).
Thus, these applications illustrate that the estimate of cell
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Figure 1. Markov-Chain Entropy (MCE) for quantifying single-cell potency in Waddington’s landscape. (A) The key assumption underlying the estimation of MCE is
that the measured gene expression profile x = (x1, . . . , xn) of a cell q is the end result of an unknown Markovian signaling process in the cell, which however we can
try to estimate by using a network model of signaling interactions. This network imposes constraints on the space of all possible Markov transition matrices, and
MCE is estimated from the one maximizing the Shannon entropy of the Markov process. Having estimated MCE for each single cell, we can then sort them according
to their MCE, which we posit is a proxy for cell potency. (B) An example of a Waddington epigenetic landscape for the Chu1 et al. dataset (Table 1), depicting four
main attractor states, representing hESCs (pluripotent), NPCs (ectoderm, multipotent), MPs (mesoderm, multipotent) and definite endoderm progenitor cells (DECs,
endoderm,multipotent). The z-axis labels the MCE values of over 1000 single cells representing these four cell types, whereas the y-axis and x-axis label the projections
inferred using t-SNE.
potency with time, as well as specific time points at which
differentiation into distinct cell fates occur.
Cellular potency encoded by the Pearson correlation
of transcriptome and connectome
In order to understand the increased robustness of MCE and
SCENT over StemID and SLICE, we note that both MCE and
SCENT integrate the scRNA-Seq data with orthogonal (i.e. com-
pletely independent) connectivity information as derived from
a PPI network [10] (Figure 1A, Methods). While such networks
are mere caricatures of the complex spatially and temporally
dependent signaling processes that take place in a cell, it is plau-
sible that there are specific robust network features that could
contribute to the observed robustness of the MCE and SCENT
measures. For instance, the difference in connectivity between
a hub and a low-degree node is likely to be true irrespective
of the PPI network considered and also likely to hold in a wide
range of different cell types and biological contexts where both
proteins are expressed at similar levels. To explore this, we first
verified that the network is indeed a critical feature underlying
the robustness of MCE as a potency measure. Specifically, using
the neural progenitor to neuron differentiation experiment from
Wang et al. [17], we observed how the discrimination accuracy
of MCE decreased significantly upon permuting the expression
values over the nodes in the network (Figure 4A–C).
Since the connectivity (or degree) profile is one of the most
fundamental properties of a network,we posited thatMCEmight
be approximated by the Pearson correlation between the tran-
scriptome and connectome.We verified that approximately 70%
of the variance in MCE can be explained by a linear correla-
tion between transcriptome and connectome (Figure 4D). In line
with this, we observed that t-statistics of differential expres-
sion between NPCs and differentiated neurons were generally
positive (i.e. higher expression in NPCs compared to neurons)
for network hubs, while low-degree nodes did not exhibit any
preference for over or underexpression (Figure 4E). We verified
that all of these patterns were a systemic feature, observed
in effectively all major datasets analyzed here (Supplementary
Figures S2–S10). Specifically, (i) the discrimination accuracy of
MCE drops significantly upon permuting expression values over
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Figure 2. Comparison of discrimination accuracy of single-cell potency measures across scRNA-Seq datasets. (A) For the scRNA-Seq dataset (Yao et al. [14]), which
profiled over 2600 cells in a time-course differentiation of hESCs (day 0) to NPCs (day 26) and finally to terminally differentiated neurons (day 54),we show corresponding
violin plots of the predicted potencies at each measured time point and for the four different potency measures (SLICE, StemID, MCE and SCENT), as indicated. The
number of cells at each time point is given below violins. (B) Left panel: Barplots compare the AUCs of the four different single-cell potency measures across 11
independent comparisons drawn from nine independent scRNA-Seq experiments (see Table 1 for definitions of cell types being compared). The AUCs reflect the
measure’s discrimination accuracy of single cells that ought to differ in terms of differentiation potential and can be derived from the statistic of a Wilcoxon rank sum
test. P-values are also derived from a one-tailed Wilcoxon rank sum test comparing cell types. Right panel: Heatmap of meta-analysis P-values comparing single-cell
potency measures to each other. P-values estimated from a paired one-tailed Wilcoxon rank sum test over the 11 independent comparisons. In the heatmaps, the
P-value entry for column i and row j is for testing the alternative hypothesis that method in row j has higher AUC values than method in column i. (C) As (B), but now
adjusting for cell-cycle phase, i.e. using only the cells with the lowest-cycling scores in each comparison group.
(ii) the Pearson correlation between trancriptome and connec-
tome explains a significant proportion of the variance in MCE;
and (iii) differentiation potency is encoded by a positive cor-
relation between transcriptome and connectome with network
hubs always preferentially overexpressed in the cells of higher
potency (Supplementary Figures S2–S10).
Biological significance of overexpressed network hubs
In order to gain a better understanding of the above phenomenon,
we performed a Gene-Set-Enrichment-Analysis (GSEA) on the
network hubs overexpressed in more potent cells. Specifically,
we considered the comparison between hESCs and NPCs, as
there were two independent scRNA-Seq datasets available
(Chu1, Yao1 and Table 1) to assess overall robustness of our
findings. Focusing first on Yao1 et al., we verified that network
hubs do indeed exhibit preferential overexpression in hESCs
compared to NPCs (Figure 5A), a result also evident in Chu1 et al.
(Figure 5B).
Performing differential expression analysis using an empir-
ical Bayes framework [18], we next ranked all network hubs
(defined as those with a degree ≥ 90) according to overex-
pression in hESCs and then again by underexpression. Of the
1406 hubs, 376 and 102 were significantly overexpressed and
underexpressed (adjusted P-value < 0.05), respectively. Perform-
ing GSEA [19] on the overexpressed subset revealed a striking
and highly significant enrichment for genes encoding stem-
ness, glutamine metabolism and mitochondrial ribosomal pro-
teins (Supplementary Table S4) with top-ranked biological terms
highly reproducible between the two independent scRNA-Seq
datasets (Figure 5C). This enrichment was only observed for
overexpressed network hubs and not for underexpressed ones
(Supplementary Figure S11, Supplementary Table S5). Corre-
sponding heatmaps of gene expression confirmed the over-
expression of mitochondrial ribosomal genes in both scRNA-
Seq datasets (Figure 5D). These findings are highly consistent
with those of a recent study, which showed that suppression of
transcription of ribosomal genes and upregulation of lineage-
specific factors in hematopoiesis coordinately control lineage
differentiation [20].
Discussion
We have here performed a comprehensive comparison between
four different single-cell potency models. All four potency mod-
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Figure 3. Three-dimensional representation of single-cell differentiation trajectories according to MCE. (A) Differentiation landscape of hepatoblasts. Figure depicts
a three-dimensional representation of single cells in an embryonic differentiation time course of mouse hepatoblasts into hepatocytes and cholangiocytes (Yang
et al.), as indicated. The MCE potency estimate labels the z-axis, whereas the x and y axes correspond to the tSNE components. Observe how the model predicts
separation/differentiation into hepatocytes and cholangiocytes at embryonic day 13 (E13) in line with the results of Yang et al. (B) Differentiation landscape of neural
precursor cells into neurons. Figure depicts a three-dimensional representation of single cells in a differentiation time course of human neural precursor cells (day 0)
into neurons (day 30) (Wang et al.), as indicated. Observe how MCE correctly predicts a gradual decrease in potency with time of differentiation.
Figure 4. Integration with network information underpins the association of MCE with cell potency. (A) Violin plots of the observed MCE values for NPCs and terminally
differentiated neurons (scRNA-Seq data fromWang et al.). P-value derives from a one-tailedWilcoxon rank sum test. (B) As (A), but now for a random permutation of the
expression values over the network, leading to a reduced discrimination accuracy. (C). Comparison of the AUC discrimination measure for the observed case [depicted
in (A)] and for 100 distinct permutations. P-value is an empirical one comparing the observed AUC to those from the 100 permutations. (D)MCE (y-axis) is approximated
reasonably well by the Pearson Correlation Coefficient (PCC) between the transcriptome and connectivity/degree profile of the network (x-axis). R2 value is given. (E)
Boxplots of t-statistics of differential expression between NPCs and neurons (y-axis) against node degree (x-axis), with larger degrees binned into equal-sized groups.
Green dashed line denotes the line t = 0. Red line is that of a linear regression. PCC is the Pearson correlation between the t-statistics and node degree. We also give
the P-value for the linear regression.
but differ significantly in terms of their construction and mean-
ing. The transcriptomic entropy used in the StemID algorithm
only uses information from the scRNA-Seq profile and approx-
imates potency in terms of the uniformity of gene expression
levels. In contrast to StemID, SLICE, SCENT and MCE use addi-
tional information to define entropy and potency. In the case
of SLICE, activity estimates are obtained for clusters of genes
with similar GO annotations, by averaging expression values of
genes in a given cluster, and with the entropy and potency sub-
sequently being calculated over these cluster activity estimates.
The hypothesis underlying SLICE is that a more uniform activity
distribution corresponds to a more potent cell. SCENT and MCE
differ from SLICE in that they don’t use GO-terms but instead
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Figure 5. Ribosomal mitochondrial genes enriched for overexpressed network hubs. (A) Boxplots of t-statistics of differential expression between hESCs and NPCs
(y-axis) in Yao1 dataset, as a function of node degree (x-axis). Green dashed line indicates the line t = 0, whereas the red line is that of least squares regression fit.
Associated PCC and P-value are given. (B) As (A), but now for Chu1 et al. dataset. (C) Scatterplot of the − log10 adjusted P-values of enrichment of the top-ranked 500
biological terms in Yao1 et al. (x-axis) against their corresponding − log10 adjusted P-values in Chu1 et al. (y-axis). In color we highlight three biological terms related
to metabolism, ribosomal mitochondrial proteins and stemness. The sizes of the circles indicate the average odds ratio over the two datasets. (D) Heatmap of gene
expression values for 32 genes encoding mitochondrial ribosomal proteins in the two scRNA-Seq datasets, stratified by hESCs and NPCs. Observe how these 32 genes
are more consistently overexpressed in hESCs compared to NPCs.
the case of SCENT, aweighted interaction network is constructed
in a cell-specific manner, with the weights reflecting interaction
probabilities derived from the gene expression profile of the cell.
Theseweights define a stochasticmatrix, fromwhich a signaling
entropy can then be defined, which quantifies the efficiency of
diffusion of signaling over the whole network. This entropy may
approximate potency if the diffusion is less efficient in more
differentiated cells, which could happen as a result of activation
of specific subnetworks which draws in signaling flux at the
expense of diffusing to other parts of the network. While MCE
also integrates the scRNA-Seq data with an interaction network,
it does not specify the signaling process but infers it from the
data itself using the observed gene expression profile of the
sample as the invariant steady-state measure of the Markov
chain. In thismodel, potency is the graph entropy of this inferred
Markov chain process, measuring the uniformity or promis-
cuity of the overall process on the network. As with SCENT,
the underlying hypothesis is that a more potent cell exhibits
a more promiscuous signaling pattern. Although information
and signaling flow is most often understood in the context of
regulatory transcription factor gene target networks, which are
directional in nature, mathematically, the diffusion or graph
entropy measures used in SCENT/MCE are equally applicable
to nondirectional networks such as the PPI networks consid-
ered here. When applying these measures to these networks
we assume that higher expression of neighboring proteins con-
tributes to increased activity of protein complexes, enzymatic
reactions and downstreamsignaling. For instance, a cell inwhich
all members of a complex are highly expressed is more likely
to have that complex activated than a cell where one or a few
members of the complex are not expressed. As we have seen,
all four potency models exhibit significant correlations with
differentiation potency in at least four of the 11 scRNA-Seq
experiments considered here. However, only MCE and SCENT
exhibited significant associations in all 10 or 11 experiments,
highlighting that some of the suggested potency models are
not robust. The observation that MCE and SCENT performed
best and that both make use of an interaction network suggests
that such information is valuable for improving the estimates of
differentiation potency. Indeed, by permuting expression values
over the network,we have shown that in all datasets considered,
the discrimination accuracy of MCE/SCENT drops significantly
[10]. Importantly, we have seen that MCE can also be approx-
imated by the Pearson correlation between the transcriptome
and connectome and that cells of higher potency tend to exhibit
higher expression of network hubs, indicating that this cor-
relation is a systemic property. Framed in the context of this
correlation between connectome and transcriptome, one can
thus understand the increased robustness of MCE and SCENT
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properties: (i) the relative connectivity between hubs and low-
degree nodes in a network is a robust feature of such net-
works; (ii) big changes in gene expression, specially at hubs, will
have a larger influence on the MCE/SCENT estimates, with such
larger changes in mRNA expression being also more robust; and
(iii) MCE/SCENT are computed genome-wide over a large number
of genes, which renders them robust to the potentially large
numbers of dropouts in scRNA-Seq data [10, 13].
Given that a positive correlation between transcriptome and
connectome is a major driver of cell potency, it is important to
discuss the nature of the factors underlying this association.
One potential factor could be related to the nature or inherent
biases of the PPI networks themselves [49, 50]. Although our PPI
network was constructed from an integrated resource encom-
passing several different PPI databases (HPRD, MINT, IntAct,
NCI-PID and BioGrid), a procedure known to reduce source-
specific biases and the false negative rate, integration of such
resources may not entirely avoid all biases. For instance, it is
well known that PPI assays are more likely to identify PPIs
for proteins that are highly expressed, and so if the source of
PPI data is preferentially skewed toward immortalized stem-
cell-like cell lines or pluripotency factors, it would follow by
construction that proteins highly expressed in stem-like cells
would have a higher connectivity in the resulting PPI network.
Thus, stemness or potency could be hardwired in the topology
of the PPI network we are considering. However, far from being
a bias that needs to be adjusted for, using such networks to
estimate potency can be viewed as a key advantage of our
approach, as this renders the potency estimation more robust in
the background of noisy scRNA-Seq data. Moreover, as we have
shown here, the association with potency is driven by a number
of different biological modules, some of which have been exper-
imentally validated (in non-PPI studies) to be associated with
cell potency. Indeed, our GSEA on overexpressed network hubs
revealed not only biological terms associated with stemness, but
also a less obvious term associated with mitochondrial ribo-
somal proteins. This enrichment and association were highly
significant and extremely robust across independent datasets
and are consistentwith recent non-PPIwork supporting a role for
mitochondrial activity and splicing rate in influencing stemness
and differentiation [20–28]. Thus, although higher expression of
such proteins will favor the detection of their interactions in
PPI assays performed on stem-like cells, their overexpression is
also of biological significance and therefore does not necessarily
constitute a factor that one would want to adjust for. Moreover,
ribosomal mitochondrial proteins don’t seem to have beenmore
extensively studied at the PPI level than say pluripotency factors
or cancer-related proteins [49–51], further supporting the view
that the observed association of MCE/SCENT with potency is
nontrivial and of novel biological significance. A more recent
study has also shown that loss of potency and fate commitment
in hematopoiesis is associated with a lower transcription rate
of ribosomal genes [20] and that this is a conserved program
across species, including higher vertebrates. Thus, while our
GSEA analysis focused on the differentiation of hESCs into NPCs,
it would appear that upregulation of ribosomal proteinsmay be a
universalmarker of differentiation potency, i.e. a potencymarker
that works for any cell type and lineage. To our knowledge, that
upregulation of ribosomal proteins may be a universal marker
of potency is an entirely novel biological insight gained through
the use of a PPI network.
We end by noting that the observed excellent agreement
between the ordering of single cells according to their differenti-
ation potency (as predicted by MCE) and their expected potency
was achieved by estimating potency for each cell individually,
starting out from a purelymodel-driven approach,without using
any prior biological information (e.g. knownmarker genes, sam-
pling time point) and without using information from other cells
(i.e. no feature selection was done, nor was clustering used to
group cells). This is in stark contrast to most single-cell algo-
rithms [29–37], whose main aim is to infer cell-lineage trajecto-
ries from time-course differentiation experiments, andwhich all
use either prior information (e.g. knownmarker gene expression,
time point) or heuristics that lack strong biological justification,
to assign cells to potency states. We propose that future single-
cell analysis algorithms should focus more on developing and
testing improved in silico models of cell potency, as this is a key
step toward a more accurate and unbiased reconstruction of
Waddington landscapes [5].
In summary, by performing a comprehensive analysis over
11 independent scRNA-Seq experiments, we have identified the
most robust single-cell potency measures, revealing that their
robustness is driven by a correlation between mRNA expression
and network connectivity. This study thus provides a foundation
to further improve upon the analysis of single-cell RNA-Seq data,
by direct in silico estimation of single-cell potency.
Key Points
• Single-cell potency can be approximated by the max-
imum network entropy of a Markov chain signaling
process on a PPI network.
• The robustness of differentiation potency measures
for single cells or bulk samples improves upon integra-
tion of the scRNA-Seq profile of a cell with orthogonal
network connectivity information, as provided by a PPI
network.
• Differentiation potency is encoded by a positive corre-
lation between transcriptome and connectome, with
network hubs exhibiting preferential overexpression
in more potent cells.
• Network hubs encoding mitochondrial ribosomal pro-
teins exhibit graded expression levels that correlate
with differentiation potency.
Supplementary Data
Supplementary data are available online at https://academic.
oup.com/bib.
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